Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin...

Area of Science:

• Endocrinology
• Metabolic Diseases
• Physiology

Background:

• Insulin is secreted in pulses, crucial for glucose regulation.
• Type 2 diabetes is characterized by impaired insulin secretion and reduced beta-cell mass.
• The relationship between beta-cell mass and insulin pulse dynamics is not fully understood.

Purpose of the Study:

• To test the hypothesis that decreased beta-cell mass causes reduced insulin pulse mass.
• To investigate the impact of reduced beta-cell mass on insulin secretion dynamics and related metabolic parameters.
• To model islet dysfunction observed in type 2 diabetes.

Main Methods:

• Induced a ~60% reduction in beta-cell mass using alloxan in a porcine model.
• Examined insulin secretion via deconvolution analysis before and after alloxan injection.
• Assessed insulin secretion during fasting, feeding, and hyperglycemic clamp conditions.
• Analyzed insulin pulse mass, frequency, and hepatic insulin clearance.

Main Results:

• Alloxan injection induced stable diabetes with significantly impaired insulin secretion (54-90% decrease).
• A selective decrease in insulin pulse mass (54-90%) was observed, with no change in pulse frequency.
• Reduced insulin pulse mass correlated with decreased hepatic insulin clearance and relative hyperglucagonemia.
• Alloxan administration emulated key aspects of islet dysfunction seen in type 2 diabetes.

Conclusions:

• A selective decrease in beta-cell mass directly leads to diminished insulin pulse mass.
• Reduced insulin pulse mass contributes to impaired glucose homeostasis by affecting hepatic insulin clearance and glucagon levels.
• This porcine model effectively replicates the pathophysiology of islet dysfunction in type 2 diabetes.